Sign in
4

Changes in Ownership

Theriva Biologics, Inc. Filed Acc 0001104659-23-010108

CEO and CFO bought 25,000 shares at $0.94 ($23,513)

From the SEC's structured data for this filing

Trades in this filing

SHALLCROSS STEVEN A · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-02 Purchase : show line 1 in the form +25,000 $0.94 $23,513 185,000 D
Open-market purchases · 25,000 sh · avg $0.94 · $23,513
Loading xslF345X03/tm235343-1_4seq1.xml…